Autoimmunity caused by disruption of central T cell tolerance. A murine model of drug-induced lupus

Journal of Clinical Investigation

Volumn 99, Issue 8, 1997, Pages 1888-1896

  Kretz Rommel, Anke ^a   Duncan, Steven R ^a   Rubin, Robert L ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

chromatin (immunology); immune tolerance; lupus (chemically induced); T lymphocytes; thymus gland (immunology)

Indexed keywords

AUTOANTIBODY; HYDROXYLAMINE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PROCAINAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CONTROLLED STUDY; DNA DENATURATION; DRUG INDUCED DISEASE; HUMAN; HUMORAL IMMUNITY; IMMUNOGLOBULIN PRODUCTION; IMMUNOLOGICAL TOLERANCE; LUPUS ERYTHEMATOSUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0030953630     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119356     Document Type: Article

References (66)

1. Yung, R.L., and B.C. Richardson. 1994. Drug-induced lupus. Rheum. Dis. Clin. North Am. 20:61-86.
2. Fritzler, M.J., and E.M. Tan. 1978. Antibodies to histones in drug-induced and idiopathic lupus erythematosus. J. Clin. Invest. 88:680-690.
3. Burlingame, R.W., and R.L. Rubin. 1991. Drug-induced anti-histone autoantibodies display two patterns of reactivity with substructures of chromatin. J. Clin. Invest. 88:680-690.
4. + T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to induce a lupus-like disease in syngeneic mice. J. Clin. Invest. 92:38-52.
5. Rubin, R.L. 1989. Autoimmune reactions induced by procainamide and hydralazine. In Autoimmunity and Toxicology: Immune Disregulation Induced by Drugs and Chemicals. M. Kammuller, M. Bloksma, and W. Seimen, editors. Elsevier, Science Publishers B. V. Amsterdam. 199-150.
6. Rubin, R.L. 1994. Role of xenobiotic oxidative metabolism. Lupus. 3: 479-482.
7. Uetrecht, J.P. 1985. Reactivity and possible significance of hydroxylamine and nitroso metabolites of procainamide. J. Pharmacol. Exp. Ther. 232: 420-425.
8. Rubin, R.L., J.P. Uetrecht, and J.E. Jones. 1987. Cytotoxicity of oxidative metabolites of procainamide. J. Pharmacol. Exp. Ther. 242:833-841.
9. Wheeler, J.F., C.E. Lunte, W.R. Heineman, L. Adams, and E.V. Hess. 1988. Rapid communications: electrochemical determination of N-oxidized procainamide metabolites and functional assessment of effects on murine cells in vitro. Proc. Soc. Exp. Biol. Med. 188:381-386.
10. Rubin, R.L., and J.T. Curnutte. 1989. Metabolism of procainamide to the cytotoxic hydroxylamine by neutrophils activated in vitro. J. Clin. Invest. 83: 1336-1343.
11. Uetrecht, J. 1989. Mechanism of hypersensitivity reactions: proposed involvement of reactive metabolites generated by activated leukocytes. Trends Pharmacol. Sci. 10:463-467.
12. Jiang, X., G. Khursigara, and R.L. Rubin. 1994. Transformation of lupus-inducing drugs to cytotoxic products by activated neutrophils. Science (Wash. DC). 266:810-813.
13. Hill, C.M., J. Lunec, H.R. Griffiths, and K.E. Herbert. 1995. Characterization of tumour necrosis factor a release by human granulocytes in response to procainamide challenge. Biochem. Pharmacol. 49:1837-1849.
14. Kubicka-Muranyi, M., R. Goebels, C. Goebel, J. Uetrechl, and E. Gleichmann. 1993. T lymphocytes ignore procainamide, but respond to its reactive metabolites in peritoneal cells: demonstration by the adoptive transfer popliteal lymph node assay. Toxicol. Appl. Pharmacol. 122:88-94.
15. Adams, L.E., K. Balakrishnan, S.M. Roberts, R. Belcher, A. Mongey, T.J. Thomas, and E.V. Hess. 1993. Genetic, immunologic and biotransformation studies of patients on procainamide. Lupus. 2:89-98.
16. Gleichmann, E., E.H. van Elven, and J.P.W. Van der Veen, 1982. A systemic lupus erythematosus (SLE)-like disease in mice induced by abnormal T-B cell collaboration. Preferential formation of autoantihodies characteristic of SLE. Eur. J. Immunol. 12:152-159.
17. Portanova, J.P., R.E. Arndt, and B.L. Kotzin. 1988. Selective production of autoantibodies in graft-vs.-host-induced and spontaneous murine lupus. Predominant reactivity with histone regions accessible in chromatin. J. Immunol. 140:755-760.
18. Rubin, R.L., F. Tang, G. Tsay, and K.M. Pollard. 1990. Pseudoautoimmunity in normal mice: Anti-histone antibodies elicited by immunization versus induction during graft-versus-host reaction. Clin. Immunol. Immunopathol. 54: 320-332.
19. Morris, S.C., R.L. Cheek, P.L. Cohen, and R.A. Eisenberg. 1990. Autoantibodies in chronic graft versus host result from cognate T-B interactions. J. Exp. Med. 171:503-517.
20. Duncan, S.R., R.L. Rubin, R.W. Burlingame, S.B. Sinclair, K.W. Pekny, and A.N. Theofilopoulos. 1996. Intrathymic injection of polynucleosomes delays autoantibody production in BXSB mice. Clin. Immunol. Immunopathol. 79:171-181.
21. Lutter, L.C. 1978. Kinetic analysis of deoxyribonuclease I cleavages in the nucleosome core: evidence for a DNA superhelix. J. Mol. Biol. 124:391-420.
22. Godfrey, J.E., A.D. Baxevanis, and E.N. Moudrianakis. 1990. Spectropolarimetric analysis of the core histone octamer and its subunits. Biochemistry. 29:965-972.
23. Burlingame, R.W., and R.L. Rubin. 1990. Subnucleosome structures as substrates in enzyme-linked immunosorbent assays. J. Immunol. Methods. 134: 187-199.
24. Rubin, R.L. 1992. Enzyme-linked immunosorbent assay for anti-DNA and antihistone antibodies including anti-(H2A-H2B). In Manual of Clinical Laboratory Immunology. N. R. Rose, E.C. de Macario, J.L. Fahey, H. Friedman, and G.M. Penn, editors. American Society for Microbiology, Washington, DC. 735-740.
25. Rubin, R.L., R.W. Burlingame, J.E. Arnott, M.C. Totoritis, E.M. McNally, and A.D. Johnson. 1995. IgG but not other classes of anti-[(H2A-H2B)-DNA] is an early sign of procainamide-induced lupus. J. Immunol. 154:2483-2493.
26. Burlingame, R.W., M.L. Boey, G. Starkebaum, and R.L. Rubin. 1994. The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus. J. Clin. Invest. 94:184-192.
27. Bell, S.A., M.V. Hobbs, and R.L. Rubin. 1992. Isotype-restricted hyperimmunity in a murine model of the toxic oil syndrome. J. Immunol. 148:3369-3376.
28. Sedgwick, J.D., and P.G. Holt. 1983. A solid-phase immunoenzymatic technique for the enumeration of specific antibody-secreting cells. J. Immunol. Methods. 57:301-309.
29. Self, C.H. 1985. Enzyme amplification: a general method applied to provide an immunoassisted assay for placental alkaline phosphatase. J. Immunol. Methods. 76:389-393.
30. Burlingame, R.W., R.L. Rubin, R.S. Balderas, and A.N. Theofilopoulos. 1993. Genesis and evolution of antichromatin autoantibodies in murine lupus implicates T-dependent immunization with self antigen. J. Clin. Invest. 91:1687-1696.
31. Theofilopoulos, A., and F.J. Dixon. 1985. Murine models of systemic lupus erythematosus. Adv. Immunol. 37:269-390.
32. Stevens, T.L., A. Bossie, V.M. Sanders, R. Fernandez-Botran, R.L. Coffman, T.R. Mosmann, and E.S. Vitetta. 1988. Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells. Nature (Lond.). 334: 255-258.
33. Kuehn, R., K. Rajewsky, and W. Mueller. 1991. Generation and analysis of interleukin-4 deficient mice. Science (Wash. DC). 254:707-710.
34. b genes in aging mice. J. Immunol. 149:230-236.
35. Roberts, S.M., L.E. Adams, R. Donovan-Brand, R. Budinsky, N.P. Skoulis, H. Zimmer, and E.V. Hess. 1989. Procainamide hydroxylamine lymphocyte toxicity. I. Evidence for participation by hemoglobin. Int. J. Immunopharmacol. 11:419-427.
36. Wheeler, J.F., L.E. Adams, A.-B. Mongey, S.M. Roberts, W.R. Heineman, and E.V. Hess. 1991. Determination of metabolically derived nitro-procainamide in the urine of procainamide-dosed humans and rats by liquid chromatography with electrochemical detection. Drug Metab. Dispos. 19: 691-695.
37. Giardina, E.-G.V., R.H. Heissenbuttel, and J.T. Bigger, Jr. 1973. Intermittent intravenous procainamide to treat ventricular arrhythmias. Ann. Intern. Med. 78:183-193.
38. Adams, L.E., C.E. Sanders, Jr., R.A. Budinsky, R. Donovan-Brand, S.M. Roberts, and E.V. Hess. 1989. Immunomodulatory effects of procainamide metabolites: their implications in drug-related lupus. J. Lab. Clin. Med. 113:482-492.
39. Adams, L.E., S.M. Roberts, R. Donovan-Brand, H. Zimmer, and E.V. Hess. 1993. Study of procainamide hapten-specific antibodies in rabbits and humans. Int. J. Immunopharmacol. 15:887-897.
40. Dayal, A.K., and G.M. Kammer. 1996. The T cell enigma in lupus. Arthritis Rheum. 39:23-33.
41. von Boehmer, H. 1994. Positive selection of lymphocytes. Cell. 76:219-228.
42. Roberts, J.L., S.O. Sharrow, and A. Singer. 1990. Clonal deletion and clonal anergy in the thymus induced by cellular elements with different radiation sensitivities. J. Exp. Med. 171:935-940.
43. a. Nature (Lond.). 345:540-542.
44. Kawai, K., and P.S. Ohashi. 1995. Immunological function of a defined T-cell population tolerized to low-affinity self antigens. Nature (Lond.). 374: 68-69.
45. Jenkins, M.K., R.H. Schwartz, and D.M. Pardoll. 1988. Effects of cyclosporine A on T cell development and clonal deletion. Science (Wash. DC). 241:1655-1658.
46. Prud'homme, G.J., R. Sander, N.A. Parley, and H. Ste-Croix. 1991. T cell maturation and clonal deletion in cyclosporine-induced autoimmunity. J. Autoimmunol. 4:357-368.
47. Urdahl, K.B., D.M. Pardoll, and M.K. Jenkins. 1992. Self-reactive T cells are present in the peripheral lymphoid tissues of cyclosporin A-treated mice. Int. Immunol. 4:1341-1349.
48. Ashton-Rickardt, P.G., and S. Tonegawa. 1994. A differential-avidity model for T-cell selection. Immunol. Today. 15:362-366.
49. Bevan, M.J., K.A. Hogquist, and S.C. Jameson. 1994. Selecting the T cell receptor repertoire. Science (Wash. DC). 264:796-797.
50. Ramsdell, F., T. Lantz, and B.J. Fowlkes. 1989. A nondeletional mechanism of thymic self tolerance. Science (Wash. DC). 246:1038-1041.
51. Amoura, Z., H. Chabre, S. Koutouzov, C. Lotton, A. Cabrespines, J.-F. Bach, and L. Jacob. 1994. Nucleosome-restricted antibodies are detected before anti-dsDNA and/or antihistone antibodies in serum of MRL-Mp 1pr/1pr and +/+ mice, and are present in kidney eluates of lupus mice with proteinuria. Arthritis Rheum. 37:1684-1688.
52. Kramers, C., M.N. Hylkema, M.C.J. van Bruggen, R. van de Lagemaat, H.B.P. Dijkman, K.J.M. Assmann, R.J.T. Smeenk, and J.H.M. Berden. 1994. Antinucleosome antibodies complexed to nucleosomal antigens show anti-DNA reactivity and bind to rat glomerular basement membrane in vivo. J. Clin. Invest. 94:568-577.
53. Monestier, M., and K.E. Novick. 1996. Specificities and genetic characteristics of nucleosome-reactive antibodies from autoimmune mice. Mol. Immunol. 33:89-99.
54. Chabre, H., Z. Amoura, J.-C. Piette, P. Godeau, J.-F. Bach, and S. Koutouzov. 1995. Presence of nucleosome-restricted antibodies in patients with systemic lupus erythematosus. Arthritis Rheum. 38:1485-1491.
55. Lefkowith, J.B., and G.S. Gilkeson. 1996. Nephritogenic autoantibodies in lupus: current concepts and continuing controversies. Arthritis Rheum. 39: 894-903.
56. Rozendaal, L., S.T. Pals, E. Gleichmann, and C.J.M. Melief. 1990. Persistence of allospecific helper T cells is required for maintaining autoantibody formation in lupus-like graft-versus-host disease. Clin. Exp. Immunol. 82:527-532.
57. McHeyzer-Williams, M.G., and G.J.V. Nossal. 1988. Clonal analysis of autoantibody-producing cell precursors in the preimmune B cell repertoire. J. Immunol. 141:4118-4123.
58. Ramsdell, F., and B.J. Fowlkes. 1990. Clonal deletion versus clonal anergy: the role of the thymus in inducing self tolerance. Science (Wash. DC). 248: 1342-1348.
59. Sebzda, E., V.A. Wallace, J. Mayer, R.S.M. Yeung, T.W. Mak, and P.S. Ohashi. 1994. Positive and negative thymocyte selection induced by different concentrations of a single peptide. Science (Wash. DC). 263:1615-1618.
60. Hogquist, K.A., S.C. Jameson, W.R. Heath, J.L. Howard, M.J. Bevan, and F.R. Carbone. 1994. T cell receptor antagonist peptides induce positive selection. Cell. 76:17-27.
61. Jameson, S.C., K.A. Hogquist, and M.J. Bevan. 1995. Positive selection of thymocytes. Annu. Rev. Immunol. 13:93-126.
62. Kretz-Rommel, A., and R.L. Rubin. 1997. A metabolite of the lupus-inducing drug procainamide prevents anergy induction in T cell clones. J. Immunol. In press.
63. Mohan, C., S. Adams, V. Stanik, and S.K. Datta. 1993. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J. Exp. Med. 177:1367-1381.
64. Desai-Mehta, A., C. Mao, S. Rajagopalan, T. Robinson, and S.K. Datta. 1995. Structure and specificity of T cell receptors expressed by potentially pathogenic anti-DNA autoantibody-inducing T cells in human lupus. J. Clin. Invest. 95:531-541.
65. Rubin, R.L., S.A. Bell, and R.W. Burlingame. 1992. Autoantibodies associated with lupus induced by diverse drugs target a similar epitope in the (H2A-H2B)-DNA complex. J. Clin. Invest. 90:165-173.
66. Lefkowith, J.B., M. Kiehl, J. Rubenstein, R. Di Valerio, K. Bernstein, L. Kahl, R.L. Rubin, and M. Gourley. 1996. Heterogeneity and clinical significance of glomerular-binding antibodies in systemic lupus erythematosus. J. Clin. Invest. 98:1373-1380.